BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30651076)

  • 1. CD1d- and PJA2-related immune microenvironment differs between invasive breast carcinomas with and without a micropapillary feature.
    Kanomata N; Kurebayashi J; Koike Y; Yamaguchi R; Moriya T
    BMC Cancer; 2019 Jan; 19(1):76. PubMed ID: 30651076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
    Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
    Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis.
    Onder S; Fayda M; Karanlık H; Bayram A; Şen F; Cabioglu N; Tuzlalı S; İlhan R; Yavuz E
    Breast J; 2017 Nov; 23(6):638-646. PubMed ID: 28543794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06).
    Yu JI; Choi DH; Huh SJ; Cho EY; Kim K; Chie EK; Ha SW; Park IA; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Koo JS; Kim JH; Jeong BG; Kim IA; Lee JH; Park W
    Clin Breast Cancer; 2015 Oct; 15(5):353-61.e1-2. PubMed ID: 25776197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
    Chen HL; Ding A
    Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
    Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
    BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma.
    Li G; Yang S; Yao J; Wang Z; Yao G; Liu M; Ye C
    World J Surg Oncol; 2016 Aug; 14(1):207. PubMed ID: 27492008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: A meta-analysis of PSM studies.
    Ye F; Yu P; Li N; Yang A; Xie X; Tang H; Liu P
    Breast; 2020 Jun; 51():11-20. PubMed ID: 32172190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case-control study.
    Yu JI; Choi DH; Park W; Huh SJ; Cho EY; Lim YH; Ahn JS; Yang JH; Nam SJ
    Breast; 2010 Jun; 19(3):231-7. PubMed ID: 20304650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases.
    Chen L; Fan Y; Lang RG; Guo XJ; Sun YL; Cui LF; Liu FF; Wei J; Zhang XM; Fu L
    Int J Surg Pathol; 2008 Apr; 16(2):155-63. PubMed ID: 18417672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Micropapillary Component Ratio on the Prognosis of Patients With Invasive Micropapillary Breast Carcinoma.
    Kaya C; Uçak R; Bozkurt E; Ömeroğlu S; Kartal K; Yazıcı P; İdiz UO; Mihmanlı M
    J Invest Surg; 2020 Jan; 33(1):31-39. PubMed ID: 29843540
    [No Abstract]   [Full Text] [Related]  

  • 12. The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis.
    Wu Y; Zhang N; Yang Q
    BMC Cancer; 2017 Dec; 17(1):839. PubMed ID: 29228910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.
    Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L
    Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma.
    Acs G; Esposito NN; Rakosy Z; Laronga C; Zhang PJ
    Am J Surg Pathol; 2010 Nov; 34(11):1637-46. PubMed ID: 20975342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast.
    Chen AC; Paulino AC; Schwartz MR; Rodriguez AA; Bass BL; Chang JC; Teh BS
    Br J Cancer; 2014 Jul; 111(3):619-22. PubMed ID: 24921921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis.
    Hao S; Zhao YY; Peng JJ; Ren F; Yang WT; Yu KD; Shao ZM
    Sci Rep; 2019 Jan; 9(1):286. PubMed ID: 30670771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: Comparative study with invasive ductal carcinoma-not otherwise specified.
    Li W; Yang D; Wang S; Guo X; Lang R; Fan Y; Gu F; Zhang X; Niu Y; Yan X; Fu L
    Pathol Res Pract; 2011 Dec; 207(12):739-46. PubMed ID: 22051146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between lymph node metastasis and pathologic features of invasive micropapillary carcinoma of breast].
    Guo XJ; Chen L; Lang RG; Fan Y; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):8-12. PubMed ID: 16608641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological Features and Prognosis of Invasive Micropapillary Carcinoma Compared to Invasive Ductal Carcinoma-NOS: Worse or Better?
    Aker FV; Ekren E; Dogan M; Gurleyik G; Tanrikulu E; Oven BB
    J Coll Physicians Surg Pak; 2022 Sep; 32(9):1196-1201. PubMed ID: 36089720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.